Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6345)
All Articles published online
|
Publishing Process of This Article
|
Jun 15, 2014 (publication date) through Dec 1, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mestier L, Manceau G, Neuzillet C, Bachet JB, Spano JP, Kianmanesh R, Vaillant JC, Bouché O, Hannoun L, Karoui M. Primary tumor resection in colorectal cancer with unresectable synchronous metastases: A review. World J Gastrointest Oncol 2014; 6(6): 156-169 [PMID: 24936226 DOI: 10.4251/wjgo.v6.i6.156] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v6/i6/156.htm |
| Number | Citing Articles |
| 1 |
Jun Huang, Jiahao Zhou, Ping Zhang, Qingbin Wu, Ziqiang Wang. Primary tumor resection for asymptomatic colorectal cancer patients with synchronous unresectable metastases: a meta-analysis of randomized controlled trials and case-matched studies. Langenbeck's Archives of Surgery 2024; 409(1) doi: 10.1007/s00423-024-03414-9
|
| 2 |
Maikel Herbrink, Bastiaan Nuijen, Jan H.M. Schellens, Jos H. Beijnen. Variability in bioavailability of small molecular tyrosine kinase inhibitors. Cancer Treatment Reviews 2015; 41(5): 412 doi: 10.1016/j.ctrv.2015.03.005
|
| 3 |
Zi-Xian Wang, Junjie Peng, Xinjun Liang, Ying Cheng, Yanhong Deng, Kehe Chen, Mingjun Zhang, Jingdong Zhang, Wei Wang, Bangwei Cao, Yongdong Jin, Meili Sun, Yuan Lin, Suxia Luo, Zhen Li, Liu Yang, Ying Ke, Haoyu Yu, Jing Li, Qingyu Wang, Jun Zhu, Feng Wang, Rui-Hua Xu. First-line serplulimab in metastatic colorectal cancer: Phase 2 results of a randomized, double-blind, phase 2/3 trial. Med 2024; 5(9): 1150 doi: 10.1016/j.medj.2024.05.009
|
| 4 |
Jiefeng Zhao, Jinfeng Zhu, Rui Sun, Chao Huang, Rongfa Yuan, Zhengming Zhu. Primary tumor resection improves prognosis of unresectable carcinomas of the transverse colon including flexures with liver metastasis: a preliminary population-based analysis. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08157-0
|
| 5 |
Jae Hyun Kim, Sol Jin, Min Ji Jeon, Hyun Yeb Jung, Sanghwan Byun, Kyoungwon Jung, Sung Eun Kim, Won Moon, Moo In Park, Seun Ja Park. Survival Benefit of Palliative Primary Tumor Resection Based on Tumor Location in Patients with Metastatic Colorectal Cancer: A Single-center Retrospective Study. The Korean Journal of Gastroenterology 2020; 76(1): 17 doi: 10.4166/kjg.2020.76.1.17
|
| 6 |
Sunu Philip, Gabriel Bakula, Michael Jacobs, Vijay K. Mittal. The Management of Patients with Colorectal Cancer and Synchronous Liver Metastases or Indeterminate Liver Lesions: A Community Teaching Hospital Experience. The American Surgeon™ 2017; 83(1): 33 doi: 10.1177/000313481708300120
|
| 7 |
Jorine 't Lam‐Boer, Lydia G. Van der Geest, Cees Verhoef, Marloes E. Elferink, Miriam Koopman, Johannes H. de Wilt. Palliative resection of the primary tumor is associated with improved overall survival in incurable stage IV colorectal cancer: A nationwide population‐based propensity‐score adjusted study in the Netherlands. International Journal of Cancer 2016; 139(9): 2082 doi: 10.1002/ijc.30240
|
| 8 |
Ruba Hamed, Sam Marks, Helen Mcelligott, Roshni Kalachand, Hawa Ibrahim, Said Atyani, Greg Korpanty, Nemer Osman. Inoperable de novo metastatic colorectal cancer with primary tumour in situ: Evaluating discordant responses to upfront systemic therapy of the primary tumours and metastatic sites and complications arising from primary tumours (experiences from an Irish Cancer Centre). Molecular and Clinical Oncology 2021; 16(2) doi: 10.3892/mco.2021.2472
|
| 9 |
Peng Yuan, Jinhua Song, Fei Wang, Guangyu Zhu, Baoan Chen. Combination of TACE and Lenvatinib as a promising option for downstaging to surgery of initially unresectable intrahepatic cholangiocarcinoma. Investigational New Drugs 2022; 40(5): 1125 doi: 10.1007/s10637-022-01257-z
|
| 10 |
Balázs Pécsi, László Csaba Mangel. The Real-Life Impact of Primary Tumor Resection of Synchronous Metastatic Colorectal Cancer—From a Clinical Oncologic Point of View. Cancers 2024; 16(8): 1460 doi: 10.3390/cancers16081460
|
| 11 |
Anna Stickel, Ute Goerling. Psycho-Oncology. Recent Results in Cancer Research 2018; 210: 163 doi: 10.1007/978-3-319-64310-6_10
|
| 12 |
Yuan Li, Silei Sui, Ajay Goel. Extracellular vesicles associated microRNAs: Their biology and clinical significance as biomarkers in gastrointestinal cancers. Seminars in Cancer Biology 2024; 99: 5 doi: 10.1016/j.semcancer.2024.02.001
|
| 13 |
Han Shuwen, Wang Yangyanqiu, Chu Jian, Hu Boyang, Chen Gong, Zhuang Jing. Synergistic effect of sodium butyrate and oxaliplatin on colorectal cancer. Translational Oncology 2023; 27: 101598 doi: 10.1016/j.tranon.2022.101598
|
| 14 |
Tim van de Loo, Fabian Kütting, Hakan Alakus, Christiane J. Bruns. Resektion des Primarius beim Kolonkarzinom mit nichtresektabler Metastasierung. Der Onkologe 2021; 27(6): 612 doi: 10.1007/s00761-021-00947-2
|
| 15 |
Erik Rasbach, Emrullah Birgin, Alexander Betzler, Nuh N. Rahbari, Christoph Reissfelder. Therapiestrategien beim synchron metastasierten Kolonkarzinom. coloproctology 2022; 44(3): 169 doi: 10.1007/s00053-022-00601-4
|
| 16 |
Levent Korkmaz, Hasan Şenol Coşkun, Faysal Dane, Bülent Karabulut, Mustafa Karaağaç, Devrim Çabuk, Senem Karabulut, Nuri Faruk Aykan, Hatice Doruk, Nilüfer Avcı, Nazım Serdar Turhal, Mehmet Artaç. Kras-mutation influences outcomes for palliative primary tumor resection in advanced colorectal cancer-a Turkish Oncology Group study. Surgical Oncology 2018; 27(3): 485 doi: 10.1016/j.suronc.2018.05.032
|
| 17 |
Akihisa Matsuda, Takeshi Yamada, Satoshi Matsumoto, Seiichi Shinji, Ryo Ohta, Hiromichi Sonoda, Goro Takahashi, Takuma Iwai, Kohki Takeda, Kumiko Sekiguchi, Hiroshi Yoshida. Systemic Chemotherapy is a Promising Treatment Option for Patients with Colonic Stents: A Review. Journal of the Anus, Rectum and Colon 2021; 5(1): 1 doi: 10.23922/jarc.2020-061
|
| 18 |
Shanu Jain, Reena Engineer, Vikas Ostwal, Anant Ramaswamy, Supriya Chopra, Ashwin Desouza, Shirley Lewis, Supreeta Arya, Prachi Patil, Avanish Saklani. Addition of short course radiotherapy in newly diagnosed locally advanced rectal cancers with distant metastasis. Asia-Pacific Journal of Clinical Oncology 2021; 17(2) doi: 10.1111/ajco.13305
|
| 19 |
Nicolas Voizard, Tiffany Ni, Alex Kiss, Robyn Pugash, Michael Jonathon Raphael, Natalie Coburn, Elizabeth David. Small Particle DEBIRI TACE as Salvage Therapy in Patients with Liver Dominant Colorectal Cancer Metastasis: Retrospective Analysis of Safety and Outcomes. Current Oncology 2022; 29(1): 209 doi: 10.3390/curroncol29010020
|
| 20 |
Ryan Margolis, Lokesh Basavarajappa, Junjie Li, Girgis Obaid, Kenneth Hoyt. Image-guided focused ultrasound-mediated molecular delivery to breast cancer in an animal model. Physics in Medicine & Biology 2023; 68(15): 155012 doi: 10.1088/1361-6560/ace23d
|
| 21 |
J. Péron, P. Rousset, G. Passot. Strategia oncochirurgica della gestione delle metastasi epatiche di origine colorettale. EMC - Tecniche Chirurgiche Addominale 2020; 26(3): 1 doi: 10.1016/S1283-0798(20)44126-9
|
| 22 |
T.E. Madiba, F. Makumbi. Digestive Diseases in Sub-Saharan Africa. 2019; : 129 doi: 10.1016/B978-0-12-815677-3.00014-1
|
| 23 |
Weijie Pan, Kaijing Wang, Jiayong Li, Hanhua Li, Yuchan Cai, Min Zhang, Aili Wang, Yazhou Wu, Wei Gao, Wenhao Weng. Restoring HOXD10 Exhibits Therapeutic Potential for Ameliorating Malignant Progression and 5-Fluorouracil Resistance in Colorectal Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.771528
|
| 24 |
Iu. V. Alimova, Yu. A. Shelygin, E. G. Rybakov. Palliative primary tumor resection in minimally symptomatic patients with colorectal cancer and synchronous unresectable metastases: when is it necessary? (systematic review). Koloproktologia 2022; 21(3): 99 doi: 10.33878/2073-7556-2022-21-3-99-110
|
| 25 |
Georgios D Lianos, Georgios K Glantzounis. Synchronous Colorectal Liver Metastases: Treatment Dilemmas and Hopes for Improving Oncological Outcomes. Future Oncology 2016; 12(15): 1743 doi: 10.2217/fon-2016-0060
|
| 26 |
Floris S. Verheij, Jonathan B. Yuval, Niels F.M. Kok, Sabrina T. Lin, Li-Xuan Qin, Dana M. Omer, Hannah M. Thompson, Iris H. Wei, Maria Widmar, Emmanouil P. Pappou, Martin R. Weiser, Garrett M. Nash, J. Joshua Smith, Philip B. Paty, Geerard L. Beets, Julio Garcia-Aguilar. Nonoperative management of the primary tumor in patients with unresectable stage IV colon cancer treated with systemic chemotherapy: Higher complication rates for left-sided colon tumors. European Journal of Surgical Oncology 2024; 50(1): 107294 doi: 10.1016/j.ejso.2023.107294
|
| 27 |
Shu-wen Liao, Jie-qun Zhan, Chu-tian Liu, Hai-tao Yu, Min-jie Wen. Survival Benefit of Primary Tumor Resection Combined With Chemotherapy in Patients With Unresectable Colorectal Mucinous Adenocarcinoma With Liver Metastasis. American Journal of Clinical Oncology 2024; 47(1): 30 doi: 10.1097/COC.0000000000001055
|
| 28 |
Junge Bai, Ming Yang, Zheng Liu, Sergey Efetov, Cuneyt Kayaalp, Audrius Dulskas, Darcy Shaw, Xishan Wang. Primary tumor resection in colorectal cancer patients with unresectable distant metastases: a minireview. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1138407
|
| 29 |
S D Nelen, M van Putten, V E P P Lemmens, K Bosscha, J H W de Wilt, R H A Verhoeven. Effect of age on rates of palliative surgery and chemotherapy use in patients with locally advanced or metastatic gastric cancer. British Journal of Surgery 2017; 104(13): 1837 doi: 10.1002/bjs.10621
|
| 30 |
Fangfang Sun, Weiwei Liang, Jing Qian. The identification of CRNDE, H19, UCA1 and HOTAIR as the key lncRNAs involved in oxaliplatin or irinotecan resistance in the chemotherapy of colorectal cancer based on integrative bioinformatics analysis. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10588
|
| 31 |
Jiefeng Zhao, Jinfeng Zhu, Chao Huang, Rongfa Yuan, Zhengming Zhu. Impact of primary tumor resection on the survival of patients with unresectable colon cancer liver metastasis at different colonic subsites: a propensity score matching analysis. Acta Chirurgica Belgica 2023; 123(2): 132 doi: 10.1080/00015458.2021.1956799
|
| 32 |
Tsuyoshi Konishi, Miguel A. Rodriguez-Bigas. Primary Tumor Resection in Colorectal Cancer with Unresectable Synchronous Metastasis: Time to Reconsider the Role of the Surgeon. Annals of Surgical Oncology 2022; 29(1): 1 doi: 10.1245/s10434-021-10949-4
|
| 33 |
Chih-Chien Wu. Comparative effectiveness of primary tumor resection versus chemotherapy in patients with asymptomatic unresectable metastatic colorectal cancer: a retrospective cohort study using the target trial emulation framework. American Journal of Cancer Research 2024; 14(5): 2172 doi: 10.62347/UGXA9515
|
| 34 |
Fang-fang Qi, Yunyao Yang, Haowen Zhang, Hongping Chen. Long non-coding RNAs: Key regulators in oxaliplatin resistance of colorectal cancer. Biomedicine & Pharmacotherapy 2020; 128: 110329 doi: 10.1016/j.biopha.2020.110329
|
| 35 |
Yefei Shu, Ling Xu, Wei Yang, Xiaofeng Xu, Song Zheng. Asymptomatic Primary Tumor Resection in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.836404
|
| 36 |
S Kader, Y Moodley, TE Madiba. The clinicopathological spectrum and treatment outcomes in metastatic colorectal cancer in the KwaZulu-Natal province of South Africa. South African Journal of Surgery 2023; 61(2): 14 doi: 10.36303/SAJS.3316
|
| 37 |
Fotios Loupakis, Giulia Maddalena, Ilaria Depetris, Sabina Murgioni, Francesca Bergamo, Angelo Paolo Dei Tos, Massimo Rugge, Giada Munari, Andrew Nguyen, Christopher Szeto, Vittorina Zagonel, Sara Lonardi, Matteo Fassan. Treatment with checkpoint inhibitors in a metastatic colorectal cancer patient with molecular and immunohistochemical heterogeneity in MSI/dMMR status. Journal for ImmunoTherapy of Cancer 2019; 7(1) doi: 10.1186/s40425-019-0788-5
|
| 38 |
Kaihong Mi, Matthew F. Kalady, Cristiano Quintini, Alok A. Khorana. Integrating Systemic and Surgical Approaches to Treating Metastatic Colorectal Cancer. Surgical Oncology Clinics of North America 2015; 24(1): 199 doi: 10.1016/j.soc.2014.09.006
|
| 39 |
George J. Chang. Primary Tumor Resection in Colorectal Cancer With Synchronous Unresectable Metastasis: Time to End the Debate?. Journal of Clinical Oncology 2021; 39(10): 1095 doi: 10.1200/JCO.21.00057
|
| 40 |
Shih-Jung Lo, Shu-Huan Huang, I-Li Lai, Yih-Jong Chern, Yu-Jen Hsu, Chun-Kai Liao, Ching-Chung Cheng, Wen-Sy Tsai, Pao-Shiu Hsieh, Jeng-Fu You. Upfront primary tumor resection versus upfront systemic therapy for metastatic colorectal cancer: a systematic review and meta-analysis. International Journal of Colorectal Disease 2023; 38(1) doi: 10.1007/s00384-023-04483-w
|
| 41 |
Wenlong Du, Xiaoping Yang, Shenfu He, Jia Wang, Yuanxian Guo, Bangguo Kou, Yongjie Jiang, Pan Bian, Bingtai Li, Lanning Yin. Novel hyaluronic acid oligosaccharide-loaded and CD44v6-targeting oxaliplatin nanoparticles for the treatment of colorectal cancer. Drug Delivery 2021; 28(1): 920 doi: 10.1080/10717544.2021.1914777
|
| 42 |
J. Péron, P. Rousset, G. Passot. Estrategia oncoquirúrgica para el tratamiento de las metástasis hepáticas de origen colorrectal. EMC - Técnicas Quirúrgicas - Aparato Digestivo 2020; 36(3): 1 doi: 10.1016/S1282-9129(20)43993-5
|